Chiesi Farmaceutici is a finished-dose manufacturer based in Italy. It appears in 642 regulatory filings across 20 regulators, without an active US DMF or CEP on file. Its filings concentrate with AIFA (IT), EMA and FAMHP (BE). Its GMP standing is certified by EMA, ANVISA (Brazil) and MFDS (Korea), among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 29 September 2023 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Parma, United Arab Emirates | Not on file |
| PARMA, Italy | Not on file |
| 43122 PARMA, Italy | Not on file |
| CAMPI BISENZIO (FI), Italy | Not on file |
| Italy, Italy | 3002806655 |
| Parma, Italy | Not on file |
1 further sites are on record.
| Regulator | Filings | GMP certificates |
|---|---|---|
| AIFA (IT) | 213 | None |
| EMA | 94 | 3 |
| FAMHP (BE) | 66 | None |
| DIGEMAPS (DO) | 61 | None |
| INFARMED (PT) | 48 | None |
| MPA (SE) | 42 | None |
| ANVISA (Brazil) | None | 3 |
| MFDS (Korea) | None | 2 |
| TMDA (TZ) | None | 1 |
| US FDA | None | 1 |
Choose your molecules and target markets. Chiesi Farmaceutici comes back tiered against every other supplier able to file there.
Start for free